ENTITY
Daiichi Sankyo

Daiichi Sankyo (4568 JP)

124
Analysis
Health CareJapan
Daiichi Sankyo Co, Ltd is a holding company established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals.
more
Refresh
21 Sep 2016 09:03

ANIMAL SPIRITS™ REPORT: Japan Equity Market Outlook - Escaping The Value Trap

Investment Conclusions We are currently "neutral" in our view on Japan in global developed market portfolios but "underweight" in our APAC...

Share
13 Sep 2016 19:39

Japan Stock Market Seasonality - Late Q4 Is Indeed Good

Pelham Smithers came out with a worthwhile comment on the Q4 seasonality of Japanese markets. I agree with their assessment of being bullish Japan...

Logo
241 Views
Share
05 Sep 2016 13:45

Short Sell Research Vs The Japan Stock Market Blob

Two recent press articles "Muddy Waters and Andrew Left: the short sellers having a ball" (...

29 Aug 2016 22:03

Japan Pharma Hits 52 Week Low

The Topix pharmaceutical index (TPPHRM) fell to 2,355 just after the lunch break in Tokyo on Friday 19th August, before recovering to 2,377, with...

20 Aug 2016 01:02

JAPAN FLOW III:  The Mechanics of BOJ Buying

This is the latest in a series of JAPAN FLOW regarding recent and forward flow dynamics of Japan equities.The first two are:    JAPAN FLOW I:  The...

Logo
326 Views
Share
x